Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart A Grossman

Showing results (91-100 of 171) with videos related to

Pageof 18
Sort By:
Oncoimmunology|May 3, 2014
Sustained CD4<sup>+</sup> T cell-driven lymphopenia without a compensatory IL-7/IL-15 response among high-grade glioma patients treated with radiation and temozolomideSusannah Ellsworth, Ani Balmanoukian, Ferdynand Kos, et al.
Neuro-Oncology|April 16, 2005
Oral sodium phenylbutyrate in patients with recurrent malignant gliomas: a dose escalation and pharmacologic studySurasak Phuphanich, Sharyn D Baker, Stuart A Grossman, et al.
Neuro-Oncology|February 22, 2008
Effect of phenytoin on celecoxib pharmacokinetics in patients with glioblastomaStuart A Grossman, Jeffrey Olson, Tracy Batchelor, et al.
Neurosurgery|December 10, 2025
Volumetric Analysis of Contrast Enhancement in Patients With Newly Diagnosed GlioblastomasMax A Saint-Germain, Mohamed Sherief, Haris I Sair, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trialStuart A Grossman, Xiaobu Ye, Marc Chamberlain, et al.
Cancer Investigation|April 9, 2004
Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: implications for patient managementLawrence R Kleinberg, Jon Weingart, Peter Burger, et al.
Neuro-Oncology Advances|February 5, 2021
Adult precision medicine: learning from the past to enhance the futureAshley Ghiaseddin, Lan B Hoang Minh, Michalina Janiszewska, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394Stuart A Grossman, Anne O'Neill, Margaret Grunnet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trialAlessandro Olivi, Stuart A Grossman, Stephen Tatter, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 21, 2015
Survival in Patients With Severe Lymphopenia Following Treatment With Radiation and Chemotherapy for Newly Diagnosed Solid TumorsStuart A Grossman, Susannah Ellsworth, Jian Campian, et al.
Pageof 18

Showing results (91-100 of 171) with videos related to

Sort By:
Pageof 18
Oncoimmunology|May 3, 2014
Sustained CD4<sup>+</sup> T cell-driven lymphopenia without a compensatory IL-7/IL-15 response among high-grade glioma patients treated with radiation and temozolomideSusannah Ellsworth, Ani Balmanoukian, Ferdynand Kos, et al.
Neuro-Oncology|April 16, 2005
Oral sodium phenylbutyrate in patients with recurrent malignant gliomas: a dose escalation and pharmacologic studySurasak Phuphanich, Sharyn D Baker, Stuart A Grossman, et al.
Neuro-Oncology|February 22, 2008
Effect of phenytoin on celecoxib pharmacokinetics in patients with glioblastomaStuart A Grossman, Jeffrey Olson, Tracy Batchelor, et al.
Neurosurgery|December 10, 2025
Volumetric Analysis of Contrast Enhancement in Patients With Newly Diagnosed GlioblastomasMax A Saint-Germain, Mohamed Sherief, Haris I Sair, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trialStuart A Grossman, Xiaobu Ye, Marc Chamberlain, et al.
Cancer Investigation|April 9, 2004
Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: implications for patient managementLawrence R Kleinberg, Jon Weingart, Peter Burger, et al.
Neuro-Oncology Advances|February 5, 2021
Adult precision medicine: learning from the past to enhance the futureAshley Ghiaseddin, Lan B Hoang Minh, Michalina Janiszewska, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394Stuart A Grossman, Anne O'Neill, Margaret Grunnet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trialAlessandro Olivi, Stuart A Grossman, Stephen Tatter, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 21, 2015
Survival in Patients With Severe Lymphopenia Following Treatment With Radiation and Chemotherapy for Newly Diagnosed Solid TumorsStuart A Grossman, Susannah Ellsworth, Jian Campian, et al.
Pageof 18